Clinical trial
Intravitreal Bevacizumab for Diabetic Macular Edema
NCT00703235 is registered in ClinicalTrials.gov with Isfahan Ophthalmology Research Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intravitreal Bevacizumab for Diabetic Macular Edema
- Lead sponsor
- Isfahan Ophthalmology Research Center
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.